Cadent Capital Advisors’s Astera Labs ALAB Stock Holding History

Cadent Capital Advisors’s Portfolio ALAB Stock Details ALAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.84M	Buy	+5,182	New	+$1.67M	0.4%	72

Other funds holding ALAB

Oak Grove Capital North Hampton, New Hampshire $2.21B AUM 127.51% 1-Year Est. Return

Integrated Financial Solutions Reston, Virginia $195M AUM 46.13% 1-Year Est. Return

Chapin Davis Baltimore, Maryland $520M AUM 117.57% 1-Year Est. Return

Mirador Capital Partners Pleasanton, California $859M AUM 41.74% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Gradient Investments Arden Hills, Minnesota $7B AUM 14.85% 1-Year Est. Return

MRA Advisory Group Parsippany, New Jersey $267M AUM 19.2% 1-Year Est. Return

Wedmont Private Capital West Chester, Pennsylvania $4.18B AUM 18.65% 1-Year Est. Return

Wealth Enhancement Trust Services Sioux Falls, South Dakota $937M AUM 18.56% 1-Year Est. Return

Juncture Wealth Strategies Scottsdale, Arizona $390M AUM 19.15% 1-Year Est. Return

Cadent Capital Advisors's ALAB Position: Q3 2026 in Review

Cadent Capital Advisors opened a new position in Astera Labs (ALAB) in Q3 2026: 5,182 shares worth $1.84M. The stake represents 0.4% of the portfolio and ranks #72 among its holdings.

27 funds tracked by Wall St. Rank hold ALAB as of Q3 2026.

Cadent Capital Advisors held 5,182 shares of Astera Labs worth $1.84M as of Q3 2026.
Astera Labs was a new Cadent Capital Advisors position in Q3 2026.
Astera Labs made up 0.4% of Cadent Capital Advisors's portfolio in Q3 2026, its #72 holding.
27 funds tracked by Wall St. Rank held Astera Labs as of Q3 2026.

Based on Cadent Capital Advisors's 13F filing for Q3 2026, filed 9 Oct 2026.